NCT06564792View on ClinicalTrials.gov

Contingency Management in HIV Care for Both Stimulant Use & ART Adherence

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

October 1, 2025

Conditions
Stimulant Use (Diagnosis)Hiv
Interventions
BEHAVIORAL

Contingency management

Once weekly contingency management visit involving 15 minutes+ of motivational interviewing and provision of incentives for stimulant-negative urine tests and/or tenofovir-positive urine tests.

Trial Locations (1)

94110

UCSF at San Francisco General Hospital, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT06564792 - Contingency Management in HIV Care for Both Stimulant Use & ART Adherence | Biotech Hunter | Biotech Hunter